Kathryn Anne Quigley

Title: Kathryn Anne Quigley: Innovator in Pharmaceutical Chemistry

Introduction

Kathryn Anne Quigley is a notable inventor based in Macclesfield, GB. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. Her work focuses on innovative methods and compositions that have potential applications in medicine.

Latest Patents

Quigley's latest patents include the development of a compound identified as 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one in crystalline Form L. This patent details methods of obtaining Form L, pharmaceutical compositions comprising Form L, and methods of using Form L and compositions that include Form L. Additionally, she has patented polymorphs of N,N-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt, along with methods of making these polymorphs and their uses.

Career Highlights

Throughout her career, Kathryn has worked with prominent companies in the pharmaceutical industry, including Kudos Pharmaceuticals Limited and AstraZeneca AB. Her experience in these organizations has allowed her to develop and refine her innovative ideas in drug formulation and delivery.

Collaborations

Some of her notable coworkers include Ezra John Still and Leonard Jesse Chyall. Their collaborative efforts have contributed to the advancement of pharmaceutical research and development.

Conclusion

Kathryn Anne Quigley is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. Her patents reflect her commitment to advancing medical science and improving therapeutic options.